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Abstract
Infection of the developing fetus with human cytomegalovirus (HCMV) is a major cause of central nervous system disease in
infants and children; however, mechanism(s) of disease associated with this intrauterine infection remain poorly
understood. Utilizing a mouse model of HCMV infection of the developing CNS, we have shown that peripheral inoculation
of newborn mice with murine CMV (MCMV) results in CNS infection and developmental abnormalities that recapitulate key
features of the human infection. In this model, animals exhibit decreased granule neuron precursor cell (GNPC) proliferation
and altered morphogenesis of the cerebellar cortex. Deficits in cerebellar cortical development are symmetric and global
even though infection of the CNS results in a non-necrotizing encephalitis characterized by widely scattered foci of virus-
infected cells with mononuclear cell infiltrates. These findings suggested that inflammation induced by MCMV infection
could underlie deficits in CNS development. We investigated the contribution of host inflammatory responses to abnormal
cerebellar development by modulating inflammatory responses in infected mice with glucocorticoids. Treatment of infected
animals with glucocorticoids decreased activation of CNS mononuclear cells and expression of inflammatory cytokines (TNF-
a, IFN-b and IFNc) in the CNS while minimally impacting CNS virus replication. Glucocorticoid treatment also limited
morphogenic abnormalities and normalized the expression of developmentally regulated genes within the cerebellum.
Importantly, GNPC proliferation deficits were normalized in MCMV infected mice following glucocorticoid treatment. Our
findings argue that host inflammatory responses to MCMV infection contribute to deficits in CNS development in MCMV
infected mice and suggest that similar mechanisms of disease could be responsible for the abnormal CNS development in
human infants infected in-utero with HCMV.
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Introduction
Viral infections in the fetus and young infant are well described
causes of abnormal brain development that often result in
permanent neurological sequelae, including disorders of motor
and cognitive functions. Altered CNS development and neuro-
logic disease have been documented in the developing fetus and
young infant following infection with a number of viruses, such as
herpes simplex virus (HSV), rubella, lymphocytic choriomenin-
gitis (LCMV) and human cytomegalovirus (HCMV) [1–7]. A
variety of mechanisms can lead to interruption of the develop-
mental program of the CNS including: damage to the brain
parenchyma secondary to apoptotic or necrotic loss of resident
cells within the CNS, damage to the supporting vasculature and
microvascular supply of the CNS resulting in decreased blood
flow and/or damage to the blood brain barrier, altered cellular
positioning and disruption of synapse formation leading to a
failure in neuronal connectivity and circuitry formation [8,9]. In
the case of infection with viruses that exhibit specific cellular
tropism, the loss or dysfunction of specific populations of resident
cells within the CNS often underlies disease. In other cases,
cellular tropism is broad and disease is thought to result from
direct viral damage to supporting structures, such as the
vasculature or the glial architecture. Additionally, indirect
mechanisms of disease following CNS infection include viral
induced host inflammatory responses [10,11]. Host responses
following virus infections often lead to more global CNS damage
secondary to the production of soluble effector molecules that can
amplify proinflammatory responses of resident cells as well as
promote cytotoxic activity by effector cells of the adaptive
immune system [12–23]. Although these mechanisms of disease,
as well as other proposed mechanisms, are consistent with clinical
findings in patients with viral encephalitis, a precise description of
the pathogenesis of CNS disease in virus infected human fetuses
and infants is often limited by the lack of informative tissue
specimens.
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Because of limitations inherent in studies of the human CNS,
small animal models have been developed to elucidate mecha-
nisms of disease associated with viral infections of the developing
CNS. These models have utilized a number of different viruses
including HSV, murine cytomegalovirus (MCMV), LCMV,
alphaviruses and more recently West Nile Virus (WNV) [4,24–
30]. Studies of CNS disease following both peripheral and
intracerebral HSV inoculation have described a necrotizing
encephalitis, which is more severe in animals with deficits in
innate and adaptive immunity [31–33]. However, more recent
studies have argued that in addition to the direct cytopathic effects
associated with HSV replication, host derived innate immune
responses contribute to CNS damage in infected mice [34,35].
Similarly, experimental models employing LCMV infection have
provided direct evidence that host-derived inflammation is a major
component of CNS disease [4,36]. In these models, limiting CD8+
virus specific T lymphocyte responses, or more global immuno-
suppression, dramatically reduced the severity of CNS disease
[4,37]. The contribution of immunopathological responses are
particularly relevant to disease in young animals because
expression of inflammatory genes during the dynamic develop-
mental program of the CNS appears to result in a disease
phenotype that differs from that seen in adult animals. Thus,
substantial CNS damage in young infants could result from
infection with viruses that are infrequently pathogenic in adults. In
contrast, an effective immune response does appear to be
necessary to limit the severity of CNS infection with alphaviruses
and WNV [24–26,38–42]. Responses derived from the adaptive
immune system, in particular the production of antiviral antibod-
ies, determine the susceptibility of newborn animals to alphavirus
infection of the CNS [25,38,43,44]. Thus disease outcome in
young animals with viral infections of the CNS reflects a balance
between unregulated inflammation and the control of virus
replication [18,32,45–51].
Intrauterine infection with HCMV is the most common cause of
congenital (present at birth) infection in humans and occurs in
approximately 1/200 live births in the United States [52]. A small
but significant number of newborn infants infected in-utero exhibit
a variety of neurodevelopmental abnormalities secondary to
HCMV infection of the CNS [5,6]. Because little is known about
the mechanisms of disease associated with this intrauterine
infection, we developed a murine model of CNS infection that
utilizes peripheral inoculation of newborn animals with limiting
amounts of MCMV. In contrast to other murine models that have
utilized intracranial inoculations of MCMV almost exclusively, the
model we have developed uses intraperitoneal inoculation of
limiting amounts of MCMV and requires virus replication in the
periphery, viremia and neuroinvasion. These latter features of this
murine model, particularly the hematogenous spread to the CNS,
appear to more closely recapitulate the presumed pathogenesis of
fetal CNS infection with human cytomegalovirus. MCMV infection
of the brain in these newborn mice results in a focal, non-necrotizing
encephalitis with little evidence of specific cellular tropism but with
global and symmetric deficits in brain development [53]. Altered
development occurred in areas of the brain that exhibited no
evidence of viral proteins or nucleic acids, suggesting that
inflammatory responses to infection, and not direct effects of virus
infection, were responsible for the altered development in the brain
of neonatal animals [53]. To determine the potential role of host
derived inflammation as a mechanism of disease in this model, we
first needed to separate the linkage between virus replication and
host inflammatory responses. This was accomplished by treating
young animals with corticosteroids to limit host responses, and
therefore inflammation, during virus infection. Although inflam-
mation in MCMV infected animals was reduced at several levels,
viral replication was unaffected. More importantly, the anti-
inflammatory activity of corticosteroids attenuated the previously
described developmental abnormalities in the cerebella of infected
animals. This finding strongly argued that virus replication was not
a direct cause of the developmental abnormalities within the CNS
following MCMV infection and suggested that inflammatory
responses played a major role in the disease phenotype [53].
Results
Focal MCMV infection of the early postnatal CNS results
in a robust inflammatory response within the CNS
In an earlier report we described altered cerebellar develop-
ment, including delayed cortical lamination, associated with
MCMV infection of the CNS in newborn mice [53]. Disruption
of lamination within the cerebellar cortex was frequently observed;
however, altered lamination in areas immediately adjacent to virus
infected cells was atypical in an overwhelming number of
examined sections. Thus, histologic evidence of direct virus
cytopathology as a cause of abnormal lamination of the cerebellar
cortex was rare (Figure 1A). The predominant histopathologic
findings of this CNS infection were widely distributed foci of virus
infected cells and surrounding mononuclear cells throughout the
cerebrum and cerebellum [53]. In contrast to the focal nature of
virus infection and mononuclear cell infiltration, defects in
cerebellar morphogenesis were global and, most importantly,
symmetric as illustrated by the delayed foliation and reduced
cerebellar area in virus infected animals (MCMV) compared to
uninfected (control) animals at post-natal day (PND) 8 (Figure 1B).
Notably, studies of infants infected in-utero by HCMV have also
described global and symmetric deficits in brain morphogenesis
without a significant component of focal or asymmetric loss of
brain parenchyma, in the majority of documented cases [6,54–61].
From these findings, we have proposed that global alterations in
cerebellar development are likely associated with soluble factors
produced by the host inflammatory response and not related to
direct effects of viral cytopathology.
Author Summary
Intrauterine infection with human cytomegalovirus
(HCMV) is a leading cause of developmental brain damage.
In the U.S., an estimated 2,000 infants a year develop brain
damage as a result of intrauterine infection with HCMV. In
this study, we examined the contribution of host immune
responses induced by CMV infection to abnormal devel-
opment of the CNS by treating neonatal mice infected
with MCMV with glucocorticoids. We found that glucocor-
ticoid treatment of infected mice decreased the inflam-
matory response within the CNS without altering the level
of virus replication. In addition, abnormalities in the
structure of the cerebellum, as well as abnormalities in
granule neuron precursor cell proliferation were normal-
ized in MCMV infected mice following glucocorticoid
treatment. These studies suggest that the host immune
response to CMV infection is damaging to the developing
CNS and that it may be possible to limit CNS disease by
modulating inflammation. Moreover, understanding how
inflammation and the immune response may alter the
developmental program within the CNS could offer
important insight into the mechanisms of disease leading
to abnormal brain development following intrauterine
infection.
MCMV Induced Inflammation Alters CNS Development
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To characterize the nature of the inflammatory response in the
cerebellum of infected animals, we analyzed several immunologic
parameters in the brains of control and infected animals at PND8.
This time point was selected because virus replication in the CNS
was established and deficits in cerebellar development were clearly
observable [53]. Initially, we assayed the phenotype of CNS
mononuclear cells in control and virus infected animals. Although
CD8+ and CD4+ T-lymphocyte infiltrates, peripheral blood
macrophages and activated microglia could be readily detected
in the cerebellar parenchyma at PND14, mononuclear cells were
present in the CNS of MCMV infected mice by PND8, prior to
the detection of infiltrating T-lymphocytes [62]. Mononuclear cells
isolated from control and infected brains were stained with two
markers for tissue macrophages, F4/80, a marker for cells of
myeloid lineage and CD45, a pan-leukocyte marker. The
differential expression of CD45 by F4/80+ cells has been
employed to distinguish between quiescent microglia (low),
activated microglia (intermediate) and infiltrating macrophages
(hi) [63]. In control animals, F4/80+ cells expressing CD45hi/int
were present in low abundance (3.0%) (Figure 2A). We observed
an increase in the proportion of CD45hi/intF4/80+ cells in the
CNS of infected mice (9%) (Figure 2A) [62]. Furthermore, MHC
class II expression was increased in this population of cells in
MCMV infected mice, a finding consistent with the activation of
these cells following infection (Figure 2B). These results demon-
strated an increase in the inflammatory response within the CNS,
including increased activation of resident macrophages and
recruitment of peripheral blood macrophages early in infection,
prior to the appearance of virus specific CD8+ T-lymphocytes. To
further define the activation state of brain macrophages in the
CNS of MCMV infected mice, cerebellar sections from PND8
control and infected animals were stained with anti-Iba-1, a
marker for activated microglia/macrophages [64,65]. In sections
from the cerebella of control mice, few Iba-1+ cells were observed
(Figure 2C). However, the number of Iba-1+ cells in the
cerebellum was significantly increased following infection with
MCMV (Figure 2C). In addition, Iba-1 staining was observed in
the meningial layer within the cerebellum of MCMV infected
animals, suggesting an infiltration of cells from the periphery
(Figure 2C). Importantly, cellular infiltrates and activated mono-
nuclear cells in the cerebellum were readily detected in the
parenchyma of the cerebellum and not limited to foci of virus
infected cells (data not shown), suggesting that the generalized
inflammation observed in the brains of MCMV infected mice was
induced by soluble mediators produced in response to virus
infection. Finally, we attempted to determine the frequency of Iba-
1+ cells with an ameboid morphology suggestive of activated
microglia and/or macrophages as compared to Iba-1+ cells with a
ramified morphology consistent with quiescent or resting microg-
lia/macrophages. We found cells consistent with both morphol-
ogies in infected and control animals but were unable to
definitively assign differences in populations between the two
experimental groups (data not shown).
Given the increase in the number of Iba-1+ cells and the
increased activation of CD45hi/intF4/80+ cells, we next quantified
the expression of inflammatory cytokines in virus-infected
cerebella by quantitative real time PCR. We selected several
proinflammatory cytokines, as well components of interferon
Figure 1. Neonatal infection with MCMV results in a focal encephalitis with global deficits within the cerebellum. A. Expression of
immediate early gene 1, protein pp89 (IE-1) (green) in the cerebellum, a non-structural protein encoded by MCMV very early in infection, PND8, 606.
Note the focal nature of infection in the external granule cell layer (EGL) of the cerebellar cortex. B. Cresyl violet staining showing a global effect of
virus infection on cerebellar area and folia development, 46. Note the smaller size, delayed foliation and delayed fissure formation in the cerebellum
of infected animals.
doi:10.1371/journal.ppat.1003200.g001
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induced responses (IFIT1 and STAT1), as markers for inflamma-
tion in the cerebella of infected animals. The expression of TNFa
(10-fold), IFNb (7-fold), STAT1 (10-fold) and IFIT1 (175-fold)
were significantly increased in infected animals as compared to
control animals (Figure 2D). Together, these results demonstrated
that by PND8 activated cells of the innate immune response and
proinflammatory cytokines were present in the developing
cerebellum of mice infected with MCMV as newborns.
Treatment of virus-infected mice with corticosteroids
decreases CNS inflammation
Thus far our findings suggested that soluble factors produced by
the inflammatory response to virus infection in the CNS were
responsible for the global alterations in cerebellar development.
Endogenous glucocorticoids have been demonstrated to protect
against immune-mediated pathology in MCMV infected adult
mice, suggesting that treatment with glucocorticoids could alter
the pathological changes in the CNS of MCMV infected newborn
mice [66,67]. To examine the effects of glucocorticoid treatment
on postnatal cerebellar development, control and MCMV infected
mice were treated with dexamethasone (dexa), a glucocorticoid
with potent anti-inflammatory activity, which has been routinely
used in the treatment of CNS inflammation in both clinical
medicine and experimental animal models of human disease
[17,68–72]. Control and MCMV infected newborn mice were
treated daily with dexa or vehicle on PND4-6 and liver, spleen,
brain and cerebellum were isolated from all groups on PND8.
There was no significant difference in the number of plaque
forming units (PFU) of virus in the spleen, liver or brain of dexa
treated/infected animals when compared to vehicle treated/
Figure 2. Infiltration of inflammatory cells and induction of proinflammatory cytokines in the brains of MCMV infected mice. A.
Percentage of CD45hi/int, F4/80+ mononuclear cells in the brain following infection with MCMV, PND8. Plots are representative of 1 of 4 replicates,
n = 4 mice pooled/replicate. B. Expression of MHC Class II, gated on CD45hi/int, F4/80+ population. Histogram is representative of 1 of 4 replicates, n = 4
mice pooled/replicate. C. Expression of Iba-1 (red), a marker for activated macrophages/microglia, and TOPROIII (blue), a nuclear marker, in the
cerebellum of control and infected mice at PND8, 206, scale bars = 50 mm. The number of Iba-1+ cells was quantified from 4 sections/animals, n = 8
mice/experimental group. Data are shown as mean +/2 SEM. P values were calculated using a two-tailed T test. D. Inflammatory gene expression in
the cerebellum of control and infected mice at PND8. Data are shown as mean +/2 SEM. P values were calculated using a two-tailed T test, n = 5
mice/experimental group.
doi:10.1371/journal.ppat.1003200.g002
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infected animals, signifying that treatment with dexa had minimal
effects on viral replication (Figure 3A). We next assessed whether
dexa treatment exhibited an anti-inflammatory effect following
MCMV infection. Dexamethasone significantly reduced the
frequency of CD45hi/intF4/80+ macrophages in the brains of
infected mice compared to vehicle treated/infected mice
(Figure 3B). Interestingly, the frequency of CD45lo F4/80+ cells
was reduced in the brains of MCMV infected mice as compared to
control and dexa treated mice suggesting that the number of
quiescent, or resting, microglia was decreased in infected animals,
perhaps secondary to an increase in activated microglia in this
experimental group ( Figure 3B). A reduction of MHC class II
expression in this population was also observed in dexa treated/
infected mice (data not shown). Similarly, the number of Iba-1+
cells was significantly decreased in the cerebellum of dexa treated/
infected mice compared to vehicle treated/infected mice
(Figure 3C). Consistent with the findings described above, the
expression of IFIT1 was significantly decreased in the cerebellum
of infected animals following treatment with dexa (Figure 3D). We
also determined that dexa treatment normalized the expression of
IFIT2 and STAT1 in the cerebellum of MCMV infected mice
(Figure 3D). Together, these results demonstrated that dexa
treatment decreased inflammation in the CNS of MCMV infected
animals without significantly altering levels of virus replication.
Treatment of MCMV infected mice with dexamethasone
normalizes cerebellar development, but has significant
off-target effects
The finding that dexa treatment of MCMV infected mice
significantly reduced the inflammatory response in the CNS raised
the possibility that dexa treatment could also prevent the aberrant
cerebellar development observed following infection. Dexameth-
asone treatment of infected mice normalized the expression of the
developmentally regulated genes gli1 and N-myc (both effectors of
the sonic hedgehog (SHH) pathway responsible for granule neuron
proliferation), as well as GABRA6 (a marker for granule neuron
differentiation) and CDK5 (primarily expressed in differentiated
neurons) (Figure 4A) [73–75]. Notably, some of these genes have
previously been shown to be altered following MCMV infection
[53]. However, dexa treatment of control animals also resulted in
a significant reduction in the expression of both GABRA6 and
CDK5 in the cerebellum when compared to control animals
receiving only vehicle (Figure 4A). These differences in expression
were not due to an effect of dexa on transcription because the
expression of Zic2, a transcription factor expressed predominantly
in granule neuron progenitors, was unaltered following treatment
(Figure 4A) [76]. Morphometric measurements from the cerebella
of infected mice demonstrated that the increased thickness of the
EGL, previously associated with delayed migration of granule
neuron progenitors, appeared to have been normalized following
treatment with dexa (data not shown). However, the EGL in dexa
treated/control animals was decreased in thickness compared to
vehicle treated/control animals (data not shown). Dexamethasone
treatment of control mice also resulted in a significant decrease in
cerebellar area when compared to vehicle treated/control mice
(Figure 4B). In addition, the cerebellar area of dexa treated/
infected animals was further decreased compared to vehicle
treated/infected animals (Figure 4B). Importantly, we did not
observe a significant increase in activated caspase 3 staining in
sections from these mice, indicating that increased apoptosis of
granule neuron progenitor cells (GNPCs) did not contribute to the
reduced size of the cerebellum in dexa treated/infected animals
(data not shown). These findings suggested that dexa treatment of
MCMV infected mice resulted in significant off-target effects in
cerebellar development, a result that would limit the interpretation
of findings from our studies of cerebellar development in dexa
treated animals. Similar off-targets effects of dexa on cerebellar
development have been previously described and thought to be
secondary to the anti-proliferative effects of this specific glucocor-
ticoid on GNPCs [77,78]. Finally, our findings raised the
possibility of an additive effect of dexa and MCMV infection on
cerebellar development.
Treatment of MCMV infected mice with prednisolone
normalizes altered cerebellar development
The off-target effects of dexa on cerebellar development have
been attributed to the resistance of this glucocorticoid to
inactivation by 11b-hydroxysteroid dehydrogenase type 2 (11b-
HSD2), an enzyme which is highly expressed in the postnatal
cerebellum in rodents as well as humans [78–80]. This enzyme is
induced by SHH during development of GNPCs in the cerebellar
cortex and appears to be protective in terms of limiting both the
apoptotic and anti-proliferative effects of corticosteroids
[78,79,81,82]. In contrast to dexa, other glucocorticoids such as
hydrocortisone and prednisolone can be inactivated by 11b-HSD2
and have not been associated with the level of off-target effects
observed following treatment with dexa [78]. Thus, we repeated
the previous experiments using prednisolone (pred), a corticoste-
roid with predominant glucocorticoid activity, which has also been
used to attenuate inflammation associated with infections of the
CNS, both in animal models and clinical medicine [69,83–86].
Control and MCMV infected newborn mice were treated once a
day on PND4-7 with vehicle or pred. This time course of
treatment was necessary secondary to the shorter in-vivo half-life
of pred compared to dexa (Figure 5A) [87,88]. Initially, we
determined the effects of pred treatment on virus replication in
MCMV infected mice. We found no significant difference between
the level of virus replication in the liver or brain of pred treated
animals compared to vehicle treated/infected animals. However,
minimal increases in viral genome copy number were observed in
both the spleen and cerebellum of pred treated/infected animals
(Figure 5B).
We next determined the effect of pred treatment on the
frequency of Iba-1+ cells in the cerebellum of both uninfected and
MCMV infected mice. As described previously, the number of
Iba-1+ cells was increased in the cerebellum of MCMV infected
mice compared to control mice (Figure 5C). Following pred
treatment, the frequency of Iba-1+ cells was reduced in MCMV
infected animals (59% reduction) compared to vehicle treated/
infected animals (Figure 5C). The number of Iba-1+ cells in pred
treated/control animals was not significantly different from the
number of positive cells in the cerebellum of vehicle treated/
control animals (Figure 5C). The observed reduction of Iba-1+
cells in the cerebellum of pred treated/infected mice indicated that
pred decreased macrophage/microglia activation in the CNS of
newborn mice following MCMV infection. In agreement with our
previous findings, treatment of infected mice with pred also
decreased the frequency of CD45hi/intF4/80+ macrophages in the
CNS of infected mice (Figure 5D). Treatment of control animals
with pred had no significant effect on either the CD45hi/intF4/80+
macrophage population or the CD45lo F4/80+ resting microglial
population (Figure 5D). The observed reduction of Iba-1+ cells in
the cerebellum and the decreased percentage of CD45hi/intF4/80+
macrophages in the CNS of pred treated/infected mice indicated
that pred decreased the number of activated macrophage/
microglia in the CNS of newborn mice following MCMV
infection.
MCMV Induced Inflammation Alters CNS Development
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Figure 3. Treatment of MCMV infected neonates with dexamethasone decreases infiltration of inflammatory cells and expression
of interferon stimulated genes in the CNS without increasing levels of virus replication. A. Infectivity assay showing viral titers in the liver,
spleen and brain of infected mice treated with vehicle or dexamethasone (dexa). Each circle represents plaque forming units (PFU)/mg of tissue for an
individual animal, p values calculated using two-tailed T test. B. (Top) Dot plots showing the percentage of CD45lo and CD45hi/int, F4/80+
mononuclear cells in the brain of infected animals following treatment with dexa, gated on mononuclear cells. Plots are representative of 1 of 4
replicates. (Bottom) Bar graphs showing the percent of CNS mononuclear cells that are CD45lo and CD45hi/int, F4/80+ macrophages. Data are shown
as mean +/2 SEM, n= 4 mice pooled/replicate, 4 replicates/experimental group. P values calculated using one-way ANOVA. C. (Top) Bar graph
depicting the number of Iba-1+ cells within the cerebellum of vehicle treated or dexa treated MCMV infected mice. Data are shown as mean +/2 SEM.
The number of Iba-1+ cells was quantified from 4 sections/animal, n = 5–8 mice/experimental group. P values calculated using two-way ANOVA.
(Bottom) Representative Iba-1 staining depicting activated macrophages within the cerebellum of vehicle treated or dexa treated infected mice,
PND8, 206 scale bars = 50 mm. (Left) Iba-1-red, TOPROIII-blue, (Right) Black and white rendering of immunofluorescent images to increase contrast,
white signals represent Iba-1 staining. D. Quantitative real-time PCR analysis of transcription of IFIT1, IFIT2 and STAT1 in the cerebellum of infected
mice following treatment with dexa. Data are shown as mean +/2 SEM, fold change normalized to control = 1, n = 5 mice/experimental group. P
values calculated using two-way ANOVA.
doi:10.1371/journal.ppat.1003200.g003
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We next determined the effects of pred treatment on the
expression of proinflammatory cytokines previously shown to be
elevated in the cerebellum following MCMV infection (Figure 2D).
Consistent with the findings described above, we observed a
reduction in the transcription of TNFa (25%), IFNb (70%) and
IFIT1 (65%) within the cerebellum of MCMV infected mice
treated with pred (Figure 6A). Pred treatment also decreased
cytokine levels of IFNb (25%) and IFNc (43%) within the
cerebellum (Figure 6B). Interestingly, cytokine levels of TNFa
were not affected following pred treatment. These results
illustrated that treatment with pred could attenuate MCMV
induced inflammation in the CNS independent of changes in virus
replication, thereby uncoupling the level of virus replication and
the host inflammatory response within the cerebellum.
Prednisolone treatment ameliorates inflammation
associated cerebellar morphogenic abnormalities in
MCMV infected mice
Since treatment with pred significantly reduced the inflamma-
tory response in the CNS and has been reported to lack the off-
target effects observed with dexa, we next determined if pred
treatment could also limit the abnormal development of the
cerebellum that was observed in MCMV infected animals.
Because of the large number of mice used in these experiments,
the variation in animal size and the size dependent variation in
brain area, we normalized measurements of cerebellar area
between experimental groups by expressing cerebellar area as a
percentage of brain area. The ratio of cerebellar area/brain area
was found to be similar for pred treated/control and pred treated/
infected animals when compared to vehicle treated/control
animals; however, vehicle treated MCMV infected mice showed
a significant reduction in this ratio (Figure 7A). These results
confirmed the decrease in cerebellar area previously observed
following infection with MCMV and, more importantly, demon-
strated normalization of altered cerebellar size in infected mice by
treatment with pred. These findings were consistent with our
hypothesis that inflammatory mediators, released in response to
MCMV infection, were a primary cause of altered cerebellar
development.
In addition to the decrease in cerebellar area, we have
previously documented an increase in the thickness of the EGL
in MCMV infected animals [53]. Since treatment of infected mice
with pred lead to normalization of cerebellar area, we next
determined whether this treatment would also normalize the
increased thickness of the EGL following infection. As expected,
the EGL was thicker in MCMV infected mice compared to
control mice. This abnormality in cerebellar development was
corrected in infected mice following treatment with pred
(Figure 7B, D). There was no measureable difference in the
thickness of the EGL in control animals treated with pred
compared to vehicle treated/control animals (Figure 7B, D). To
determine if the increase in the thickness of the EGL following
Figure 4. Treatment with the glucocorticoid dexamethasone normalizes developmental gene expression in the brains of infected
mice but leads to cerebellar hypoplasia. A. Cerebellar expression of developmentally regulated genes from uninfected and infected mice
treated with vehicle or dexa analyzed by quantitative real-time PCR. Data are shown as mean +/2 SEM, fold change normalized to control = 1, n = 5
mice/experimental group. P values calculated using two-way ANOVA. B. Quantification of cerebellar area (expressed as a percentage of total brain
area) in mice treated with vehicle or dexa. Data are shown as mean +/2 SEM, measurements were taken from 5 sections/mouse, n = 5–7 mice/
experimental group. P values were calculated by two-way ANOVA.
doi:10.1371/journal.ppat.1003200.g004
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infection was secondary to an increase in cellularity, the number of
GNPCs in the EGL was quantified. Consistent with an increase in
thickness, we found an increase in the number of GNPCs within
the EGL following infection (Figure 7C). Concomitant with
normalizing the increased thickness of the EGL, treatment of
infected mice with pred also normalized the number of GNPCs
within the EGL. We did not find any significant difference in the
number of GNPCs in the EGL between vehicle treated/control
animals or pred treated/control animals (Figure 7C). The
normalization of MCMV induced abnormalities in the morpho-
genesis of the cerebellar cortex following treatment with pred
demonstrated that we could limit morphogenic abnormalities
within the cerebellum of infected mice by modulating inflamma-
tory responses.
Prednisolone attenuates inflammation associated
impairments in cerebellar granule neuron precursor
differentiation
Previously, we documented that following infection, morpho-
logical deficits within the cerebellum coincided with a significant
reduction in the transcription of developmentally regulated genes
expressed within GNPCs [53]. Since pred treatment reduced
inflammation and corrected morphological deficits within the
cerebellum of infected mice, we hypothesized that pred treatment
could also correct abnormalities in the transcription of these
genes. Similar to our studies using dexa, we assayed gli1, N-myc,
GABRA6 and CDK5 expression in the cerebella of uninfected
and MCMV infected mice treated with vehicle or pred.
Consistent with our previous findings, expression of both
GABRA6 and CDK5 was decreased following infection with
MCMV when compared to control mice (Figure 7E). Following
treatment with pred the expression of both genes was normalized
within the cerebella of MCMV infected mice. Similarly, the
transcription of gli1 and N-myc was elevated in the cerebellum
following infection and treatment of infected mice with pred
decreased the expression of both genes (Figure 7E). Importantly,
pred treatment had no effect on the transcription of gli1, N-myc,
GABRA6 or CDK5 in control animals (Figure 7E). As a control,
the expression of Zic2 was analyzed and was found to be similar
in the cerebella of all groups (Figure 7E) [76]. These results
indicated that decreasing inflammation in MCMV infected
animals by treatment with pred normalized the expression of
developmentally regulated genes in the absence of measurable
off-target effects.
Figure 5. Treatment with prednisolone decreases the infiltration of inflammatory cells into the brain of MCMV infected mice. A.
Schematic showing the time course of MCMV infection and prednisolone (pred) treatment. B. Quantitative real-time PCR for IE-1 showing viral
genome copy number in the liver, spleen, brain and cerebellum of infected mice treated with vehicle or pred. P values calculated by Mann-Whitney
test, n = 22–25 mice/experimental group for liver, spleen and brain; n = 5–7 mice/experimental group for cerebellum. C. (Top) Quantification of Iba-1+
cells in the cerebellum of vehicle or pred treated, control and infected mice. Data shown as mean +/2 SEM. P values calculated by two-way ANOVA.
Iba-1+ cells were counted in 4 sections/animal, n = 6 mice/experimental group. (Bottom) Panels of representative sections analyzed by confocal
microscopy showing Iba-1 staining (red) and TOPROIII (blue) in the cerebellum of control or infected mice treated with vehicle or pred. Panel below
represents black and white rendering of immunofluorescent images to increase contrast, white signals represent Iba-1+ cells. All images taken at 206,
scale bars = 50 mm. D (Left) Representative dot plots showing the percentage of CD45lo and CD45hi/int, F4/80+ macrophages in the brain of vehicle or
pred treated animals, gated on mononuclear cells. Plots are representative of 1 of at least 3 replicates, n = 4 mice pooled/replicate. (Right) Bar graphs
showing the percentage of mononuclear cells that are CD45lo and CD45hi/int, F4/80+ macrophages in the CNS. Data are shown as mean +/2 SEM,
n = 4 mice pooled/replicate, 3–5 replicates/experimental group. P values were calculated using two-way ANOVA.
doi:10.1371/journal.ppat.1003200.g005
Figure 6. Treatment of infected neonatal mice with prednisolone decreases the expression of proinflammatory cytokines and
interferon stimulated genes in the brain of MCMV infected mice. A. Quantitative real-time PCR analyzing the transcription of TNFa, IFNb and
IFIT1 in the cerebellum. Fold changed normalized to control = 1. Data shown as mean +/2 SEM. P values calculated by two-way ANOVA, n = 5 mice/
experimental group. B. Concentration of TNFa, IFNb and IFNc in the cerebellum of PND8 control and infected mice treated with vehicle or pred. Data
are shown as mean +/2 SEM, n= 3 cerebella pooled/replicate, 3 replicates/experimental group. P values were calculated using two-way ANOVA.
doi:10.1371/journal.ppat.1003200.g006
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Altered granule neuron proliferation following MCMV is
corrected subsequent to treatment with prednisolone
In MCMV infected mice, the upregulation of gli1 and N-myc
was inconsistent with the deficit in GNPC proliferation observed
in our previous studies [53]. This suggests that an alternative
mechanism could be responsible for the deficit in GNPC
proliferation within the cerebellum of infected mice [53]. Given
our previous findings (increased thickness of the EGL, decreased
GNPC differentiation, decreased GNPC migration to the IGL and
decreased thickness of the IGL), we postulated that a block or
delay within the GNPC cell cycle, downstream from the actions of
gli1 and N-myc, would be most consistent with our observations.
The failure of GNPCs to complete a program of proliferation in
the EGL would prevent their differentiation and subsequent
Figure 7. Treatment with the glucocorticoid prednisolone limits altered morphogenesis and developmental gene expression in the
cerebella of MCMV infected mice. A. Cerebellar area of control or MCMV infected mice treated with vehicle or pred. Data are shown as mean +/2
SEM. Stereological measurements from 5 sections/mouse, n = 5 mice/experimental group. P values calculated using two-way ANOVA. B. External
granule cell layer (EGL) thickness in vehicle or pred treated control and MCMV infected mice. Data are shown as mean +/2 SEM. EGL thickness was
determined from 4 measurements/section, 8 sections/mouse, n = 6–8 mice/experimental group. P values calculated using two-way ANOVA. C.
Granule neuron progenitor cells (GNPCs) in the cerebella of control and infected mice treated with vehicle or pred. Data are shown as mean +/2 SEM.
GNPC numbers from 8 sections were counted per mouse, n = 5–6 mice/experimental group. P values calculated using two-way ANOVA. D.
Representative cerebellar sections showing a thickening of the EGL following MCMV infection that is corrected with pred treatment, 606, scale
bars = 20 mm. EGL containing GNPCs are shown in white, the adjacent molecular layer is shown in black. E. Transcription of developmentally
regulated genes within the cerebellum of vehicle or pred treated, control and infected mice. Data are shown as mean +/2 SEM. Fold change
normalized to control = 1, n = 5 mice/experimental group. P values calculated using two-way ANOVA.
doi:10.1371/journal.ppat.1003200.g007
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migration into the IGL. This mechanism would also account for
the increased cellularity of the EGL and the decreased cellularity
of the IGL in infected animals [53,89–91]. To investigate this
possibility, PND8 animals were injected with BrdU, a marker of
cells in S phase. Serial sections from the cerebellum were stained
with antibodies reactive with BrdU and Ki67, a marker of cycling
cells, and the number of positive cells was quantified for each
marker (Figure 8A). No difference was observed in the percent of
total GNPCs that were positive for Ki67 in the EGL of MCMV
infected animals compared to control animals (Figure 8B).
However, a decrease in the percent of cycling cells (Ki67+)
positive for BrdU was detected in infected animals when compared
to control animals (Figure 8C). The decrease in BrdU reactivity
within GNPCs of infected mice was therefore not secondary to a
decrease in the overall number of cells in the cell cycle. Moreover,
the previously described minimal level of apoptosis of GNPCs in
either group of animals indicated that there is likely a block or
delay in the cell cycle of GNPCs following infection [53].
If the inflammatory response in the CNS of infected mice
contributed to the block/delay in the proliferation of GNPCs, our
results described above would argue that the anti-inflammatory
effects of pred could alleviate this block and restore the
proliferative capacity of GNPCs in the EGL. Analysis of Ki67
expression in pred treated groups revealed that the percent of
GNPCs in the cell cycle was similar to that of infected or control
animals that were treated with vehicle (Figure 8B). When
compared to vehicle treated/control animals there was no
significant difference in the percent of BrdU+ cells in EGL of
Figure 8. Treatment with the glucocorticoid prednisolone normalizes granule neuron progenitor cell proliferation in MCMV
infected mice. A. Representative images of brain sections depicting the expression of cell cycle markers in the EGL of control or infected mice
treated with vehicle or pred; BrdU (green), Ki67 (red), TOPROIII (blue), 606, scale bars = 20 mm. B–C. Stereological quantification of BrdU+ and Ki67+
GNPCs in the EGL of vehicle or pred treated, control and infected mice. Data are shown as mean +/2 SEM, 8 sections were counted per mouse, n = 5–
6 mice/experimental group. P values calculated using two-way ANOVA. Vehicle treated control vs. MCMV were significantly different (p#.001) as
determined by two-tailed T test. D. (Top) Detection of phospho-cyclin B1 and cyclin B1 in the cerebellum by immunoblotting. Actin loading control
shown at bottom. Each lane represents 2 cerebella pooled, n = 2 lanes/experimental group. (Bottom) Densitometry showing the expression of p-
cyclin B1, relative to actin, in the cerebellum of vehicle or pred treated, control and infected animals. Data are representative of 3 replicate blots. P
value calculated by two-way ANOVA. Control vs. MCMV were significantly different (p#.02) as determine by two-tailed T test.
doi:10.1371/journal.ppat.1003200.g008
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pred treated/infected animals indicating that pred treatment of
infected animals normalized the deficit in GNPC proliferation
associated with MCMV infection (Figure 8C). Importantly, the
percent of BrdU+ GNPCs in the EGL of pred treated/control
animals was not significantly different from vehicle treated/control
animals. Together, these findings argue that pred treatment
alleviated alterations in the cell cycle of GNPCs that were
associated with MCMV infection. Furthermore, these results
support our hypothesis that modulating the inflammatory response
following MCMV infection could limit deficits in cerebellar
morphogenesis, likely through reversing the delay in GNPC
proliferation.
To further define the disruption in the cell-cycle of GNPCs
following infection we assayed the levels of two cyclins, cyclin D1
and cyclin B1, in control and MCMV infected mice. Levels of
cyclin D1 were not significantly different between control or
infected animals, suggesting that infection with MCMV did not
alter the signals associated with entry of GNPCs into G1 (data not
shown) [92]. Similarly, pred treatment did not alter cyclin D1
levels in infected or control animals (data not shown). Although
there was no observable difference in the levels of total cyclin B1
expression between infected and control mice (Figure 8D), the
level of phosphorylated-cyclin (p-cyclin) B1, a marker for G2/M,
was decreased within the cerebella of infected animals compared
to control animals (Figure 8D) [93,94]. Together with the
decreased number of BrdU+ GNPCs, this data further argued
for a block/delay in the cell cycle following infection. Cerebella
from both control and MCMV infected mice treated with pred
displayed levels of p-cyclin B1 that were similar to vehicle treated/
control mice (Figure 8D). Although this data did not reveal the
precise point where cell cycle progression was delayed, it further
confirmed that altered development of the cerebellum in infected
animals was associated with delayed proliferation of GNPCs
within the EGL. Treatment with pred corrected this deficit and
normalized the morphological abnormalities within the cerebel-
lum following infection. These results were consistent with a
mechanism in which the developmental abnormalities associated
with focal encephalitis in MCMV infected newborn mice resulted
from the host inflammatory response as opposed to a direct virus-
mediated mechanism.
Discussion
Previously we have shown that intraperitoneal inoculation of
newborn mice with MCMV resulted in a focal CNS infection that
involved all regions of the brain that but did not exhibit specific
cellular tropism [53]. Histologically, the foci consisted of a small
number of virus-infected cells, mononuclear cells and reactive
astroglial cells [53]. Although there was no observable difference
in the size of the cerebrum between infected and uninfected
animals, cerebellar hypoplasia was readily apparent in infected
animals and was associated with delayed foliation and decreased
area of the cerebellar cortex, findings attributable to the decreased
proliferation of GNPCs within the EGL [53]. Morphogenic
abnormalities of the cerebellar cortex included increased thickness
of the EGL, decreased thickness of the IGL, abnormal arboriza-
tion of Purkinje neuron dendrites and thinning of the molecular
layer [53]. Interestingly, the altered morphogenesis of the
cerebellum was symmetric even though foci containing virus
infected resident cells and infiltrating mononuclear cells were
scattered widely throughout the parenchyma of the cerebellum.
These later findings strongly argued that the developmental
abnormalities were secondary to a soluble mediator generated
during virus-induced inflammatory responses in the CNS and not
from direct cytopathic effects of virus infection. In this report, we
have described findings consistent with this mechanism; specifi-
cally, evidence that attenuation of inflammatory responses in
infected mice, by treatment with anti-inflammatory glucocorti-
coids, normalized developmental abnormalities in the cerebellum
without affecting the level of virus replication.
Our results demonstrated that several measures of GNPC
proliferation were altered in MCMV infected mice, including a
decrease in the frequency of cells in S phase and a decrease in the
levels of phospho-cyclin B1 within the EGL of MCMV infected
mice. Several explanations could account for these findings,
including a decrease in the number of GNPCs entering the cell
cycle, premature exit of GNPCs from the cell cycle and a block or
delay in the cell cycle of GNPCs following infection. Premature
exit of GNPCs from the cell cycle represented an obvious
explanation for the decreased cerebellar size but other measures
of GNPC proliferation were inconsistent with this explanation.
The increased cellularity of the EGL following MCMV infection
and the similar percentages of Ki67+ GNPCs in infected and
control mice argued that there was no difference in the number of
GNPCs entering the cell cycle nor was there an increased number
of GNPCs exiting the cell cycle. Because we found a decrease in
certain markers of proliferation but no change in the number of
cycling GNPCs following MCMV infection in this study as well as
in a previous study, a more consistent interpretation of our data is
that the cell cycle of GNPCs in the EGL is prolonged in MCMV
infected animals [53]. Prolongation of the cell cycle could delay
the completion of the programmed proliferation and subsequent
differentiation of GNPCs that is required for normal morphogen-
esis of the cerebellar cortex. Variation in the rate of cell division of
GNPCs in the EGL has been described, suggesting that the
duration of the cell cycle in these cells is not autonomous and can
be influenced by extracellular cues [90,95,96]. Though we have
not fully characterized the nature of this alteration in the cell cycle
of GNPCs, it was reversible, in that the delay was corrected when
MCMV infected animals were treated with glucocorticoids.
Although a unifying mechanism for the normalization of
cerebellar development in pred treated MCMV infected mice
remains incompletely described, our results were most consistent
with a decrease in the inflammatory response in the CNS leading
to normalization of the proliferative capacity of GNPCs in the
cerebellar cortex. This mechanism is based on previous studies
that have demonstrated that GNPCs undergo what is thought to
be a programmed number of cell divisions prior to exiting the cell
cycle, entering a differentiation program and then migrating from
the EGL into deeper layers of the cerebellar cortex [90,95,96].
This well choreographed developmental pathway has been
extensively studied and many of the molecular signals associated
with this pathway have been described [74,91,95–100]. We are
proposing that if the cell cycle of GNPCs is prolonged, subsequent
to inflammation in the cerebellum, then normal morphogenesis of
the cerebellar cortex fails to take place and the expression of
developmentally regulated genes that depend on differentiation
and correct cellular positioning will be delayed. Findings from this
study are consistent with a reversible, generalized slowing of the
GNPC cell cycle in infected mice. Reversal of this slowing could be
expected to result in a rebound in GNPC proliferation, permitting
the completion of the developmentally programmed cell divisions,
differentiation into migrating granule neurons, migration into the
IGL and expression of the associated differentiation genes. The
reversibility of this mechanism is consistent with the partial
resolution of defects in cerebellar development observed in vehicle
treated MCMV infected mice following virus clearance and
regulation of the inflammatory response later in infection [53].
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Additional support for the reversibility of a slowing of the cell cycle
has been reported in a study of 11b-HSD2 2/2 transgenic mice
treated with corticosterone [79]. Findings from this study
demonstrated a rebound in the cerebellar area and the size of
the IGL in these transgenic mice following withdrawal of steroid
treatment [79]. Even though the effector molecules and pathways
that lead to altered proliferation of GNPCs and cerebellar
development in this model of a human CNS infection remain
undefined, such a mechanism could argue for a common pathway
leading to the developmental abnormalities associated with
inflammation following infection of the developing brain of the
fetus and newborn infant by a number of microbial agents.
Alteration in the rate of proliferation of progenitor cells in the
developing CNS could lead to deficits in developmental, stage
dependent cell positioning and potentially result in a number of
long term neurological abnormalities.
A recent study that carefully detailed the effects of glucocorti-
coids on the developing cerebellum described several phenotypes
following treatment with different glucocorticoids [78]. These
investigators demonstrated that the phenotypic response of
GNPCs to glucocorticoids was dependent on the presence of
11b-HSD2, an enzyme that is expressed at higher levels in the
cerebella of both newborn rodents and humans as compared to
other regions of the CNS [78–80,101]. Previous studies have
indicated that the inactivation of glucocorticoids by 11b-HSD2
limits the anti-proliferative and apoptotic inducing activities of
endogenous and exogenous glucocorticoids [78,79]. Because
dexamethasone (dexa) is not efficiently inactivated by 11b-
HSD2, treatment of neonatal mice with dexa resulted in increased
GNPC apoptosis (short term treatment) or decreased GNPC
proliferation (chronic treatment), secondary to exit from the cell
cycle presumably from accelerated GNPC differentiation [77,78].
Interestingly, in this study chronic prednisolone (pred) treatment
resulted in an intermediate phenotype due to the inactivation of
this specific glucocorticoid by 11b-HSD2 [78]. Our findings were
consistent with the results presented in this report in that treatment
with dexa, but not pred, resulted in a significant decrease in the
size of the cerebellar cortex in both uninfected and infected mice.
We also noted that in two independent experiments the cerebellar
area in dexa treated/infected mice was smaller than that of both
dexa treated/control mice or vehicle treated MCMV infected
mice. These findings suggested that the effects of dexa and
MCMV infection were additive and raised the possibility that the
effect of dexa on GNPC proliferation in this setting differed from
those that followed MCMV infection. Interestingly, dexa treat-
ment did result in normalization of the expression of genes
associated with GNPC differentiation (GABRA6 and CDK5) in
the absence of normalization of GNPC proliferation, a finding
consistent with accelerated GNPC differentiation in animals
following treatment with dexa [77,78]. The premature exit of
GNPCs from the cell cycle likely accounted for the cerebellar
hypoplasia and decreased cerebellar area that was observed in
dexa treated animals. In contrast, when infected mice were treated
chronically with pred, we observed a correction of the abnormal
cell cycle of GNPCs that was also associated with normalization of
the morphogenic abnormalities in the cerebellar cortex. Following
normalization of the cell cycle in pred treated animals, GNPCs
completed their programmed proliferation in the EGL, migrated
into the deeper layers of the cerebellum and expressed develop-
ment specific genes. We have not identified a specific mecha-
nism(s) to explain the correction of proliferation deficit(s) in
GNPCs following pred treatment, but it is unlikely that in pred
treated mice, GNPCs exited the cell cycle and differentiated as was
observed in dexa treated mice. This argument is based on three
findings; (i) a similar frequency of GNPCs were cycling in both
pred treated and vehicle treated mice, (ii) the frequency of BrdU+
GNPCs in the EGL was increased following pred treatment and
(iii) measures of cerebellar morphogenesis (EGL thickness,
cerebella area and EGL cellularity) were normalized in infected
mice following treatment with pred. Several experimental models
of CNS infection in newborn animals have also noted beneficial
outcomes following treatment with anti-inflammatory agents, but
in some cases and in contrast to our findings, increased disease
severity secondary to increased replication of the microorganism
was also observed [17,67,68]. Experimental rodent models of
herpes simplex encephalitis have demonstrated a beneficial effect
of steroid treatment when combined with an antiviral agent
suggesting that host-derived inflammation contributes to the
outcome of CNS infection with this virus [102,103]. In findings
that paralleled our results, treatment of Borna disease virus (BDV)
infected adult rats with dexa limited inflammation and also
appeared to improve neurologic function in infected animals [17].
In clinical medicine, the use of glucocorticoids to limit CNS
inflammation in patients with mycobacterial infections of the brain
is well established [69,70]. These agents have also been utilized to
limit neurological sequelae that follow bacterial meninigitis
associated with pyogenic bacteria [71]. Several studies have
demonstrated that glucocorticoids efficiently limit the innate
immune response to microorganisms in the CNS, including the
expression of proinflammatory cytokines, chemokines and inter-
feron stimulated genes [17,104]. However, the use of glucocorti-
coids, particularly dexa, in young infants remains controversial
because of the well documented adverse effects this agent has on
brain development [105,106].
The importance of SHH in the proliferation of GNPCs in the
cerebellar cortex has been studied extensively [107–113]. The
proliferation of these neuron progenitors in response to SHH has
been reported to involve the transcription factors gli1 and N-myc
[109,114–117]. It was therefore somewhat unexpected to find that
expression of both gli1 and N-myc was increased in the cerebella of
MCMV infected mice as compared to control mice. Interestingly,
we noted that transcription of patched (Ptch) was also increased in
the cerebella of MCMV infected mice, a finding that paralleled the
increased expression of gli1 and could represent a regulatory
response to SHH induced responses [118,119]. We do not have a
definitive explanation for the increase in gli1 and N-myc
expression but noted that when MCMV infected mice were
treated with glucocorticoids the expression of these SHH effectors
was normalized. Consistent with our observations, previous reports
have suggested that proinflammatory cytokines can modulate the
SHH pathway [120,121]. As an example, increases in GNPC
proliferation have been documented in transgenic mice with
constitutive IFNc expression in the CNS [122]. In these engineered
mice, SHH and gli1 expression was induced by IFNc via a STAT1
dependent pathway. More recent studies have reported that IFNc
treatment of cultured granule neurons leads to increased prolifer-
ation and that STAT1 binds directly to the SHH promoter
[123,124]. Interestingly, both IFNc and STAT1 were upregulated
in the cerebella ofMCMV infected mice coincident with an increase
in the expression of N-myc and gli1 (Figure 3D; Figure 6B).
Moreover, treatment with pred reduced the cytokine levels of IFNc
and normalized the expression of both N-myc and gli1 following
MCMV infection. Studies of cytokines during CNS development
have detailed both neuroprotective and deleterious roles, suggesting
a delicate balance between the homeostatic and immune functions
of cytokines in the developing CNS [125–128]. Our findings suggest
that cytokines released following neonatal infection with MCMV
could have deleterious effects on developing GNPCs within the
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cerebellum and that modulating the inflammatory response associ-
ated with this infection could limit damage to the developing CNS.
An important aspect of this study is that the pathological and
histopathological findings in this murine model appear very similar
to those reported in human infants with congenital CMV infection.
The focal encephalitis, characteristic of MCMV infection in mice,
has also been noted in autopsy findings from infants with congenital
HCMV infections. Furthermore, in this model histopathological
findings of mononuclear cell infiltrates and reactive gliosis, termed
micronodular gliosis, are remarkably similar to those found in
infected human infants [55,57,60,129,130]. Cerebellar hypoplasia is
an invariant finding in this murine model and also frequently
reported in infants with congenital HCMV infections that have been
studied by imaging or, in a smaller number, following autopsy
[57,131,132]. Reports describing MRI findings in infants with
congenital HCMV infection have suggested that cerebellar hypo-
plasia is characteristic of this intrauterine infection. However, it
should also be noted that the murine model we have developed has a
significant limitation, dictated by the route of virus inoculation and
the age of the developing brain at the time of infection. CNS
development in newborn mice is believed to be at a stage similar to
that of a mid to late 2nd trimester human fetus. Thus, in the murine
model we have developed, cortical damage associated with an earlier
gestational age of fetal infection will not be adequately modeled. Yet
it is also important to note that the vast majority of infants with
congenital HCMV infections also do not exhibit structural damage
to the cerebral cortex, raising the possibility that only a minority of
infants are infected early in gestation. In agreement with this
possibility, recent studies have provided evidence suggesting that
transmission of virus to the developing fetus occurs more frequently
in the later stages of pregnancy [133]. Thus, with the awareness of
limitations inherent in studies carried out in rodents, we would argue
that the findings we have generated from our studies suggest that
inflammation in the developing brain should be considered a
potential contributor to at least some of the developmental
abnormalities that have been associated with intrauterine HCMV
infections. Furthermore, if inflammation and the soluble mediators
present in the CNS account for the altered proliferative capacity of
neural progenitor cells, our results could be extrapolated as a
potential explanation for maldevelopment of the brain associated
with other intrauterine infections resulting in CNS inflammation.
Even though our findings in this murine model of congenital
CMV infection have demonstrated a beneficial effect of glucocor-
ticoid therapy in maintaining the developmental program during
MCMV infection, we cannot directly extrapolate our findings in
this model system to human disease or other infections of the CNS.
However, the potential intersections between neurodevelopmental
pathways and those that contribute to CNS inflammation in
neonatal animals would suggest that more selective approaches to
limiting CNS inflammation could open new therapeutic avenues
and lead to improved outcomes. These approaches combined with
antiviral therapy, to limit virus replication until host responses can
efficiently clear virus from the CNS, could offer a more optimal
approach for management of this important perinatal infection.
Further exploitation of this model could provide insight into the
feasibility of such an approach and perhaps aide in defining
markers of CNS inflammation, allowing for a more selective
introduction of anti-inflammatory therapy.
Materials and Methods
Ethics statement
All animal breeding and experiments were performed in accor-
dance to the guidelines of the University of Alabama – Birmingham
Institutional Animal Care and Use Committee (IACUC) in strict
compliance with guidelines set forth by the NIH (OLAW Assurance
Number - A3255-01). Research was conducted under a protocol
approved by IACUC. All experiments done at the University of
Rijeka were in accordance with the University of Rijeka – Croatia
animal use and care policies in accordance to the guidelines of the
animal experimentation law (SR 455.163; TVV) of the Swiss Federal
Government.
MCMV infection and corticosteroid treatment
Infection of mouse pups was performed as previously described
[53]. Briefly, newborn Balb/c mice (6–18 hrs post-partum) were
infected with 500 PFU of MCMV-Smith (ATCC VR-1399) by i.p.
(intraperitoneal) inoculation. Control and MCMV infected pups
were treated on PND4-6 by i.p. injection with dexamethasone
sodium phosphate (dexa; APP Pharmaceuticals); 1 mg/kg in 50 ml
of sterile PBS. Dexa was administered once a day and mice were
sacrificed on PND8 between 36 and 42 hours after the last
treatment was administered. For Prednisolone experiments,
animals were treated with prednisolone sodium phosphate (pred;
commercial pharmacy); 7 mg/kg (equivalent to 1 mg/kg dexa) in
50 ml of sterile PBS on PND4-7. Treatments were administered
once a day and mice were sacrificed on PND8 between 16 and
18 hrs post injection. As a control, uninfected and MCMV
infected animals were given i.p. injections with 50 ml sterile PBS
alone (vehicle). Animals were sacrificed on PND8, perfused with
ice cold PBS and organs were harvested and processed for the
appropriate downstream application. All mice were purchased
from The Jackson Laboratory (Bar Harbor, ME).
Virus growth and titer analysis
Stocks of MCMV-Smith strain were propagated by infection of
mouse embryonic fibroblasts (MEFs). Infected media was harvest-
ed at 5–7 days post-infection and frozen at 280uC. For dexa
experiments, organs were collected, weighed and homogenized. A
10% homogenate in media was utilized for standard plaque assays
[134]. For pred experiments, organs were collected and DNA was
isolated using Trizol according to the manufacturer’s instructions
(Roche Applied Science). 1 mg of DNA was then used for
quantitative real-time PCR with the following primers for MCMV
IE-1 Exon 4: Forward: 59-GGC TTC ATG ATC CAC CCT GTT A –
39; Reverse: 59-GCC TTC ATC TGC TGC CAT ACT – 39. Primers
were used at a concentration of 250 nM/reaction. The following
FAM-TAMRA (BHQ-2) probe was used at a concentration of
300 nM/reaction for real-time detection: 59-/56-FAM/AGC CTT
TCC TGG ATG CCA GGT CTC A – 39. Real time PCR was
performed by Taqman based assay using the StepOne Plus system
from Applied Biosystems (Carlsbad, CA).
Immunofluorescence, immunohistochemistry and
cerebellar morphometry
For immunofluorescence studies, mice were injected on PND8
with 50 mg/g of BrdU (Sigma Aldrich) in 16PBS, 6 hrs. prior to
harvest. Mice were then perfused with PBS and brains were fixed
in 4% paraformaldehyde (PFA) overnight, cryoprotected in 30%
sucrose-PBS and embedded in Tissue Tek O.C.T. compound
(Andwin Scientific). 8-mm sagittal sections were cut using a Leica
cryostat. Cut sections were dried for 4 hours at room temperature
(RT), rehydrated in 16 PBS then used for immunofluorescence
assays. For Iba-1 staining, sections were blocked in 16PBS, .05%
Triton X-100, 20% normal goat serum, 5% BSA for 2 hr. at RT.
Sections were then stained with anti-Iba-1 overnight at 4uC.
Subsequently, sections were washed with PBS, .05% Triton X-100
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and then incubated for 2 hrs. at RT in the dark with secondary
antibody, followed by a 15 min. incubation with TOPRO-3 iodide
(1:1000, Molecular Probes) at RT. Following staining for Iba-1,
sections were post-fixed with 2% PFA for 20 min. at RT. Sections
were washed and mounted using Vectashield Fluorescent mount-
ing medium (Vector Laboratories). For BrdU/Ki67, sections were
blocked in 16 PBS, 1% Triton X-100, 20% normal goat serum,
1 M glycine, 5% BSA for 1 hr. at RT. Blocking was followed by a
2 N HCL acid wash for 10 min. on ice, 10 min. at RT and
20 min at 37uC. Sections were then buffered in .1 M Borate buffer
for 12 min. at RT, washed in PBS, 1% Triton X-100 and labeled
as previously described. Primary antibodies utilized in this study
were anti-Iba-1 (1:200, Wako, Japan), anti-Ki67 (1:200, ab66155;
Abcam), anti-IE1 (Chroma101 [53]) and anti-BrdU (1:50, ab6326;
Abcam). Secondary antibodies used were: Alexa Fluor 594 -
conjugated anti-Rabbit; Alexa Fluor 488 - conjugated anti-mouse
(Molecular Probes) and Goat anti-Rat – FITC (Southern Biotech),
respectively. Images of stained sections were collected by using an
Olympus Fluoview confocal microscope (206 objective for Iba-1
and 606 objective for BrdU/Ki67). For cell counts, images were
saved as TIFF files and opened in Image J [135]. An area box was
created and the number of cells in the EGL within this box was
counted for each section.
Frozen sections were used for all morphometric measurements.
EGL measurements were done on serial sections using Image J
software. Measurements were obtained from sections stained with
BrdU, Ki67 and TOPRO3. Images were collected with a confocal
microscope. 4 measurements were taken from the primary fissure
of the EGL in each section and 8 serial sections were measured per
animal. For area measurements, the first 5 sections in each series
were stained with 1% cresyl violet in ethanol for 10 min. followed
by washing with 16PBS until dye no longer ran off. Sections were
mounted with 50% glycerol, 50% PBS and pictures were taken
using an Olympus BX41 microscope with a 26 objective.
Representative sections showing a close up of the cerebellum used
in the paper were obtained with a 46 objective. Cerebellar area
and brain area was measured using Image J software [135].
Flow cytometry
CNS mononuclear cells were isolated by using a percoll density
gradient protocol [62]. Isolated cell populations were stained in
FACS buffer (2% BSA and 0.2% sodium azide) for 30 min at 4uC
in the dark and fixed in 2% PFA. All samples were stained with
CD45-FITC and F4/80-APC (eBioscience) and MHCII-IA/IE
(Biolegend). Samples were acquired using a FACSCalibur (BD
Biosciences) flow cytometer and analyzed using FlowJo7.6.1.
Due to low cell number and poor cell viability, mononuclear cell
isolations from neonatal brain was performed as follows for
prednisolone treated groups. Brains were homogenized using a
GentleMACs tissue homogenizer (Milteniy Biotech). Homoge-
nates were strained through a 40 mm nylon strainer, followed by
centrifugation at 4006g for 4 min at 4uC. Homogenates were
washed once with 16PBS (without Ca++/Mg++) and centrifuged
again at 4006g, 4 min at 4uC. Mononuclear cells were isolated by
resuspending the pellet in a 37% continuous Percoll gradient
followed by centrifugation at 6906g for 20 min, 4uC with gentle
braking. Pellets were washed once with FACS buffer (16PBS, 2%
BSA, .2% Sodium Azide), then lysed for 5 min with 1 ml RBC
lysis buffer (Sigma Aldrich). Lysis was inhibited by adding 10 mls
FACS buffer and the pellet was collected by centrifugation
(4006g, 4 min at 4uC). Pellets were again washed with FACS
buffer, followed by resuspension in FACS buffer with FC block
(1:100, eBioscience). Mononuclear cells were blocked for 30 min
on ice, counted using a TC20 cell counter (Bio-Rad) and 100 ml of
cell suspension was transferred to individual wells of a round
bottom, polystyrene 96 well plate. 100 ml of FACS buffer was
added to each well and the plate was centrifuged (4006g, 4 min at
4uC) to pellet the cells. Mononuclear pellets were washed 26with
FACS buffer, followed by staining with CD45 – PerCP (1:300),
Cd11b – PE (1:200) and F480 – FITC (1:300) (eBioscience) for
1 hr at 4uC in the dark. Following staining, 150 ml of FACS buffer
was added to each well and cells were pelleted by centrifugation.
Cells were again washed 26with FACS buffer followed by fixation
with 4% PFA for 20 min at 4uC in the dark. Following fixation,
cells were washed 26 with FACS buffer, resuspended in 200 ml
FACS buffer and transferred to 5 ml polystyrene FACS tubes (BD
Falcon). Samples were acquired using a FACSCalibur (BD
Biosciences) flow cytometer and analyzed using FlowJo7.6.1.
Dexamethasone experiments were repeated using this protocol
and data were compared to the previous protocol. No differences
were observed in the frequency of CD45lo or CD45hi/int/F480+
mononuclear cell populations in any group when compared to our
previous findings; however, mononuclear cell numbers were
greatly improved.
Quantitative real time PCR
Total cerebellar RNA from control and experimental mice was
isolated using Trizol reagent (Roche Applied Science); 500 ml
Trizol/cerebellum according to manufacturer’s protocol. cDNA
from each sample was synthesized using the Superscript III First
Strand synthesis kit (Invitrogen). Taqman based real time PCR
was employed for determining the mRNA expression of genes of
interest in experimental animals relative to uninfected controls.
Taqman assay mixes for TNF-a (Mm99999068), IFN-b
(Mm00439552), STAT1 (Mm00439518), IFN-c (Mm99999071),
gli1 (Mm00494645), N-myc (Mm00476449), Zic2 (Mm01226725),
CDK5 (Mm00432437) and GABRA6 (Mm01227754) were
obtained from Applied Biosystems. Real time PCR was performed
using the StepOne Plus system from Applied Biosystems. The
housekeeping gene 18S was used as a control for all experiments.
The fold change (target gene expression relative to 18S) for control
animals was set to a value of 1 +/2 SEM and the relative fold
change for each experimental group was determined by normal-
izing to control animals.
ELISA
Cerebella were harvest from PND8 animals. Samples were
pooled (3 cerebella/sample) and homogenized in ELISA buffer
(16PBS, .25% Triton X-100) containing protease/phosphatase
inhibitors (Thermo Scientific). Lysates were rotated for 20 min at
4uC then sonicated 36 for 5 sec, followed by centrifugation at
12K6 g for 10 min at 4uC. Aliquots were made and stored at
280uC until use. ELISAs were performed according to the
manufacturer’s instructions: TNFa (eBioscience), high sensitivity
IFNc (ebioscience, San Diego, CA) and IFNb (PBL Interferon
Source). Cytokine concentrations (pg/ml) were normalized for
amount of tissue used (mg).
Immunoblot of cerebellar lysates
Cerebella harvested from control and experimental groups at
PND8 were homogenized in RIPA buffer (50 mM Tris-HCl,
NaCl 150 mM, 1% NP-40, 0.25% Na-Deoxycholate, 1 mM
EDTA) containing protease/phosphatase inhibitors (Thermo
Scientific) and cleared of insoluble material by centrifugation at
12K6 g. 50 mg of protein solubilized in sample buffer (5%
SDS,2% 2-mercaptoethanol, Tris pH 8) and separated by SDS-
PAGE electrophoresis using a 10% acrylamide gel. Electropho-
retically separated proteins were immobilized on nitrocellulose
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membranes and used for Western blot analysis. Membranes were
probed overnight at 4uC for actin (1:1000, MAB1501; Millipore),
cyclin D1, cyclin B1 and phospho-Cyclin B1 (Ser 147) (1:500,
2978, 4138 and 4131 respectively; Cell Signaling Technology).
Immunoblots were incubated for 1 hr with HRP-conjugated anti-
mouse or anti-rabbit secondary antibodies (Southern Biotech) then
developed with ECL reagent (Perkin Elmer). Densitometry was
performed using Quantity One software (Bio-Rad) and levels of
protein were normalized to actin for each lane.
Statistics
Statistical significance of comparisons of mean values was
assessed by a two-tailed Student’s t test, one-way analysis of
variance (ANOVA) followed by Bonfferronni’s multiple compar-
ison test, two-way ANOVA followed by Bonfferronni’s posttest, or
a Mann-Whitney test using Prism 4 software (GraphPad).
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